What is the current price and volume for GV.PA stock?

GV.PA stock last traded at **€0.0018** (rounded **€0.002**) on EURONEXT with volume **38,489,238.00** shares today. Average volume is **14,217,513.00**, so the session shows a significant volume spike.

How does Meyka AI rate GV.PA and what does that mean?

Meyka AI rates GV.PA with a score out of 100: **62.45** (Grade **B**, Suggestion **HOLD**). The grade blends benchmark, sector and company metrics and is informational, not investment advice.

What are the main risks for investing in GV.PA?

Main risks include negative earnings (**EPS -0.11**), weak equity, **current ratio 0.91**, and thin liquidity. Microcap volatility and potential dilution from capital raises are additional concerns.

What is Meyka AI's price forecast for GV.PA?

Meyka AI's forecast model projects **€0.0040** over 12 months, implying **+122.22%** from the exact last trade **€0.0018**. Forecasts are model-based projections and not guarantees.

EU Stocks

GV.PA Genomic Vision SA EURONEXT 23 Mar 2026: Intraday most-active, volume spike

ByDanny Kontos March 23, 2026March 23, 2026

GV.PA stock opened the EURONEXT session at €0.002 (exact €0.0018) on 23 Mar 2026 and posted a 5.88% intraday rise as volume surged to 38,489,238.00 shares. The move makes Genomic Vision SA (GV.PA) one of the most active small-caps in Europe today. Traders are reacting to thin-cap liquidity, stretched technical averages and company partnerships in diagnostics. We examine trading patterns, valuation metrics and the short-term outlook for investors and active traders on EURONEXT.